Physician profile
Ulrike Berth
NPI 1487852398
$424.39
in general payments reported to CMS, 2019-2025
11 companies · $48.11 in 2025
The $48.11 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.33 · 2020: $56.28 · 2021: $25.90 · 2022: $65.05 · 2023: $64.86 · 2024: $66.86 · 2025: $48.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $179.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $122.47 | 2021-2025 | Caldolor |
| Chiesi USA, INC. | $112.87 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $53.97 | 2020-2024 | Bridion |
| Avanos Medical | $28.64 | 2019 | |
| Werfen USA LLC | $23.44 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.76 | 2025 | Exparel |
| Ardelyx, INC. | $15.58 | 2023 | Ibsrela |
| Vertex Pharmaceuticals Incorporated | $14.96 | 2025 | |
| Acelrx Pharmaceuticals, INC. | $11.95 | 2019 | |
| Redhill Biopharma INC. | $11.66 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ulrike Berth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.